• Login
    Search 
    •   RD&E Research Repository Home
    • Specialist Services
    • Search
    •   RD&E Research Repository Home
    • Specialist Services
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 21

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    • Molecular Basis of Developmental Anomalies of the Human Gastrointestinal Tract 

      Shaw-Smith, Charles (Morgan & Claypool, 2015-12-11)
      Current knowledge of the etiology of congenital malformations of the human gastrointestinal tract is covered in this book, prefaced by some introductory notes on embryological development. Malformations involving the ...
    • Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers. 

      Clarke, T L; White, D. A.; Osborne, Melanie; Shaw, A M; Smart, Neil J.; Daniels, Ian R. (Royal College of Surgeons, 2017-05)
      Introduction The aim of this study was to identify patient factors including serum biomarkers that may predict response to neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer staged on ...
    • Subclinical colonic thickening. 

      Oades, Patrick; Rosenthal, M.; Mac Sweeney, E.J.; Bush, A. (Sage, 1996)
    • Pharmacological interventions for recurrent abdominal pain in childhood. 

      Martin, A. E.; Newlove-Delgado, T. V.; Abbott, R. A.; Bethel, A.; Thompson-Coon, J.; Nikolaou, V.; Logan, Stuart (Cochrane Library, 2014-02-14)
      This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effectiveness of pharmacological interventions for RAP in children of school age.
    • Digesting GWAS 

      Turnpenny, Peter D. (Elsevier, 2016-07-28)
    • Measuring infliximab and adalimumab drug and antibodies in Crohn's disease and ulcerative colitis 

      Perry, Mandy; McDonald, Timothy J.; Cudmore, Adrian; Ahmad, Tariq (Clinical Laboratory International, 2015-11-02)
      The anti-TNF therapies infliximab and adalimumab have revolutionized the treatment of inflammatory bowel disease, being very effective in many patients. Some patients experience problems such as loss of response, which is ...
    • Exfoliated colonocyte DNA levels and clinical features in the diagnosis of colorectal cancer: a cohort study in patients referred for investigation. 

      Mahadavan, L.; Loktionov, A.; Daniels, Ian R.; Shore, Angela; Cotter, D.; Llewelyn, A. H.; Hamilton, W. (Wiley, 2012-03)
      Selection of patients for investigation of suspected colorectal cancer is difficult. One possible improvement may be to measure DNA isolated from exfoliated cells collected from the rectum.
    • Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study. 

      Walker, Gareth; Moore, L.; Heerasing, Neel; Hendy, Peter; Perry, Mandy; McDonald, Timothy J.; Debenham, T; Bethune, Rob; Bewshea, Claire M.; Hyde, Chris; Heap, Graham A.; Singh, A.; Calvert, Christopher; Kennedy, Nicholas A.; Goodhand, James Ross; Ahmad, Tariq (Wiley, 2018-04)
      Primary care faecal calprotectin testing distinguishes inflammatory bowel disease (IBD) from functional gut disorder in young patients presenting with abdominal symptoms; however, previous evaluations have excluded patients ...
    • Psychosocial interventions for recurrent abdominal pain in childhood 

      Martin, Alice E.; Newlove-Delgado, T.V.; Abbott, R. A.; Bethel, A.; Thompson-Coon, J.; Nikolaou, V.; Logan, Stuart (Wiley, 2017-01-10)
      This review supersedes the original Cochrane review first published in 2008 (Huertas-Ceballos 2008).Between 4% and 25% of school-aged children complain of recurrent abdominal pain (RAP) severe enough to interfere with their ...
    • Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. 

      Meyer, T.; Fox, R.; Ma, Y. T.; Ross, P. J.; James, M. W.; Sturgess, R.; Stubbs, C.; Stocken, D. D.; Wall, L.; Watkinson, Anthony; Hacking, N.; Evans, T. R. J.; Collins, P.; Hubner, R. A.; Cunningham, D.; Primrose, J. N.; Johnson, P. J.; Palmer, D. H. (Elsevier, 2017-08)
      Transarterial chemoembolisation (TACE) is the standard of care for patients with intermediate stage hepatocellular carcinoma, while the multikinase inhibitor sorafenib improves survival in patients with advanced disease. ...
    • 1
    • 2
    • 3

    Browse

    All of RD&E Research RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Discover

    AuthorAhmad, Tariq (5)Hendy, Peter (4)Kennedy, Nicholas A. (4)McDonald, Timothy J. (4)Perry, Mandy (4)Walker, Gareth (4)Bewshea, Claire M. (3)Chanchlani, Neil (3)Daniels, Ian R. (3)Goodhand, James R. (3)... View MoreSubject
    Gastroenterology (21)
    Oncology. Pathology. (4)Paediatrics (4)Biochemistry (1)calprotectin (1)diagnostic tests (1)gastroenterology (1)Haematology (1)IBD (1)Microbiology. Immunology (1)... View MoreDate Issued2010 - 2020 (20)1996 - 1999 (1)Has File(s)No (15)Yes (6)

    DSpace software copyright © 2002-2021  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV